The role of high sensitivity C-reactive protein in coronary artery disease risk prediction: a review.
Abou Diwan
Charbel H
CH
School of Biosciences, University of Westminster, United Kingdom.
Oghlakian
Gerard O
GO
Antonios
Samer I
SI
Otrock
Zaher K
ZK
Rebeiz
Abdallah G
AG
D001241:Aspirin / Q000627:therapeutic use; D002097:C-Reactive Protein / Q000032:analysis*; D002986:Clinical Trials as Topic; D015331:Cohort Studies; D016001:Confidence Intervals; D003327:Coronary Disease / Q000097:blood* / Q000453:epidemiology* / Q000517:prevention & control; D005260:Female; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D008297:Male; D009391:Nephelometry and Turbidimetry / Q000379:methods; D016017:Odds Ratio; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011237:Predictive Value of Tests; D011322:Primary Prevention; D011379:Prognosis; D011446:Prospective Studies; D012306:Risk; D018570:Risk Assessment; D012307:Risk Factors; D012680:Sensitivity and Specificity; D012737:Sex Factors
D000960:Hypolipidemic Agents; D010975:Platelet Aggregation Inhibitors; D002097:C-Reactive Protein; D001241:Aspirin